Exact Sciences Corp (EXAS)
65.96
-1.98
(-2.91%)
USD |
NASDAQ |
Sep 27, 16:00
65.99
+0.03
(+0.05%)
Pre-Market: 20:00
Exact Sciences SG&A Expense (Annual): 1.620B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.620B |
| December 31, 2022 | 1.583B |
| December 31, 2021 | 1.663B |
| December 31, 2020 | 1.071B |
| December 31, 2019 | 737.63M |
| December 31, 2018 | 427.46M |
| December 31, 2017 | 262.91M |
| December 31, 2016 | 189.73M |
| December 31, 2015 | 140.14M |
| December 31, 2014 | 69.31M |
| December 31, 2013 | 22.88M |
| December 31, 2012 | 14.26M |
| December 31, 2011 | 10.96M |
| Date | Value |
|---|---|
| December 31, 2010 | 8.093M |
| December 31, 2009 | 9.775M |
| December 31, 2008 | 6.469M |
| December 31, 2007 | 8.532M |
| December 31, 2006 | 10.70M |
| December 31, 2005 | 10.85M |
| December 31, 2004 | 12.74M |
| December 31, 2003 | 14.63M |
| December 31, 2002 | 11.74M |
| December 31, 2001 | 12.87M |
| December 31, 2000 | 4.814M |
| December 31, 1999 | 1.560M |
| December 31, 1998 | 1.17M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
737.63M
Minimum
2019
1.663B
Maximum
2021
1.335B
Average
1.583B
Median
2022
SG&A Expense (Annual) Benchmarks
| Quest Diagnostics Inc | 1.642B |
| Illumina Inc | 1.612B |
| Guardant Health Inc | 451.03M |
| Natera Inc | 618.31M |
| Castle Biosciences Inc | 180.15M |